Fusion Pharmaceuticals Inc.（FUSN）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · FUSN · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2023-12	2022-12	2021-12	2020-12	2019-12
Revenue
Revenue	$2.07M	$1.46M	$1.44M	$0.00M	$0.00M
Cost of Revenue	$1.34M	$58.90M	$56.36M	$0.48M	$0.29M
Gross Profit	$0.72M	($57.43M)	($54.92M)	($0.48M)	($0.29M)
Gross Margin %(computed)	34.96%	—	—	—	—
Operating Expenses
R&D Expenses	$68.76M	$58.90M	$56.36M	$17.19M	$10.63M
G&A Expenses	$31.20M	$30.60M	$27.10M	$20.74M	$7.59M
Total Operating Expenses	$99.95M	$89.50M	$83.45M	$37.94M	$18.04M
Operating Income	($99.23M)	($88.03M)	($82.02M)	($37.94M)	($18.22M)
Operating Margin %(computed)	—	—	—	—	—
Interest Income	$9.53M	$2.16M	$0.38M	$0.33M	$0.58M
Interest Expense	$5.17M	$1.80M	$0.00M	$0.33M	$0.00M
Income Before Tax	($94.11M)	($89.45M)	($81.17M)	($75.72M)	($15.94M)
Income Tax Expense	$0.79M	($1.84M)	($0.12M)	$2.61M	$0.25M
Net Income	($94.90M)	($87.61M)	($81.05M)	($78.33M)	($16.19M)
Net Margin %(computed)	—	—	—	—	—
Per Share & EBITDA
EPS (Basic)	$-1.45	$-2.00	$-1.90	$-3.56	$-0.10
Wtd Avg Shares	65.61M	43.75M	42.60M	22.03M	155.71M
EBITDA	($87.60M)	($87.26M)	($81.38M)	($31.05M)	($17.75M)
EBITDA Margin %(computed)	—	—	—	—	—